Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)


Matzinger O., Heimsoth I., Poortmans P., Collette L., Struikmans H., Van Den Bogaert W., ...More

ACTA ONCOLOGICA, vol.49, no.1, pp.24-34, 2010 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 49 Issue: 1
  • Publication Date: 2010
  • Doi Number: 10.3109/02841860903352959
  • Title of Journal : ACTA ONCOLOGICA
  • Page Numbers: pp.24-34

Abstract

Introduction. The EORTC 22922/10925 trial investigated the potential survival benefit and toxicity of elective irradiation of the internal mammary and medial supraclavicular (IM-MS) nodes Accrual completed in January 2004 and first results are expected in 2012. We present the toxicity reported until year 3 after treatment.